scholarly journals Restless legs syndrome, pica, and iron status in blood donors

Transfusion ◽  
2013 ◽  
Vol 53 (8) ◽  
pp. 1645-1652 ◽  
Author(s):  
Bryan R. Spencer ◽  
Steven Kleinman ◽  
David J. Wright ◽  
Simone A. Glynn ◽  
David B. Rye ◽  
...  
2004 ◽  
Vol 5 (2) ◽  
pp. 115-118 ◽  
Author(s):  
Jan Ulfberg ◽  
Birgitta Nyström

Blood ◽  
2012 ◽  
Vol 120 (21) ◽  
pp. 2283-2283
Author(s):  
Barbara J. Bryant ◽  
Yu Ying Yau ◽  
Sarah M. Arceo ◽  
Julie A. Hopkins ◽  
Susan F. Leitman

Abstract Abstract 2283 Background: Pica and restless legs syndrome (RLS) are associated with iron depletion and deficiency. Pica refers to the compulsive craving for and persistent consumption of non-nutritive substances. Pagophagia, the pathological consumption of ice, is a specific pica strongly associated with iron deficiency. RLS is a neurological movement disorder characterized by uncomfortable sensations in the lower extremities, with a compelling urge to move the extremities to relieve the discomfort. Primary RLS is a central nervous system disorder; however, secondary RLS may be caused or exacerbated by iron deficiency. The purpose of this study was to prospectively assess the prevalence of pica and RLS in blood donors presenting to a hospital-based donor center, to correlate the findings with donor hemoglobin and iron levels, and to study the effects of oral iron replacement on the resolution of symptoms. Methods: During a 39-month period, 1236 blood donors deferred for fingerstick hemoglobin <12.5 g/dL and 400 non-deferred “control” donors underwent health screening and laboratory testing (CBC, ferritin, iron, transferrin). Iron deficiency was defined as a ferritin level below the institutional reference range of 9 mcg/L in females and 18 mcg/L in males. Iron depletion was defined as a ferritin of 9 – 19 mcg/L in females and 18 – 29 mcg/L in males. Pica and RLS were assessed by direct questioning. Deferred donors and iron-deficient control donors were given ferrous sulfate 325 mg daily for 60 days. Reassessments were performed and additional iron tablets dispensed at subsequent visits. Results: Pica was reported in 11% of donors with iron depletion/deficiency, compared with 4% of iron-replete donors (p<0.0001). The prevalence of pica rose to 21% in females with ferritin <9 mcg/L. Pagophagia (ice pica) was most common and was often of extraordinary intensity, with characteristics of an addiction. Donors with pagophagia given iron reported a marked reduction in the desire to eat ice by day 5–8 of therapy, with disappearance of symptoms by day 10–14. RLS was reported in 16% of subjects with iron depletion/deficiency compared with 11% of iron-replete donors (p=0.012). Iron replacement generally resulted in improvement of RLS symptoms, however, at least 4–6 weeks of iron therapy was necessary. The positive predictive values of pica and RLS in iron deficient/depleted blood donors were 73% and 58%, respectively. Conclusion: The presence of pica is highly predictive of iron depletion/deficiency in blood donors; however, RLS lacks a strong correlation in this population. Screening questions for pica, in particular pagophagia, may be useful in the ascertainment of iron depletion and deficiency in blood donors and may identify those who would benefit from oral iron therapy. Disclosures: No relevant conflicts of interest to declare.


Vox Sanguinis ◽  
2013 ◽  
Vol 107 (1) ◽  
pp. 44-49 ◽  
Author(s):  
B. Pedrazzini ◽  
S. Waldvogel ◽  
P. Vaucher ◽  
J. Cornuz ◽  
R. Heinzer ◽  
...  

Nutrients ◽  
2020 ◽  
Vol 12 (5) ◽  
pp. 1313
Author(s):  
Susanne Macher ◽  
Cornelia Herster ◽  
Magdalena Holter ◽  
Martina Moritz ◽  
Eva Maria Matzhold ◽  
...  

Background: Besides anemia, iron deficiency may cause more subtle symptoms, including the restless legs syndrome (RLS), the chronic fatigue syndrome (CFS) or sleeping disorders. Objective: The aim of this pre-planned secondary analysis of the IronWoMan randomized controlled trial (RCT) was to compare the frequency and severity of symptoms associated with iron deficiency before and after (intravenous or oral) iron supplementation in iron deficient blood donors. Methods/Design: Prospective, randomized, controlled, single-centre trial. (ClinicalTrials.gov: NCT01787526). Setting: Tertiary care center in Graz, Austria. Participants: 176 (138 female and 38 male) whole-blood and platelet apheresis donors aged ≥ 18 and ≤ 65 years with iron deficiency (ferritin ≤ 30ng/mL at the time of blood donation). Interventions: Intravenous iron (1 g ferric carboxymaltose, n = 86) or oral iron supplementation (10 g iron fumarate, 100 capsules, n = 90). Measurements: Clinical symptoms were evaluated by a survey before iron therapy (visit 0, V0) and after 8–12 weeks (visit 1, V1), including questions about symptoms of restless legs syndrome (RLS), chronic fatigue syndrome (CFS), sleeping disorders, quality of life and symptoms like headaches, dyspnoea, dizziness, palpitations, pica and trophic changes in fingernails or hair. Results: We found a significant improvement in the severity of symptoms for RLS, fatigue and sleep quality (p < 0.001). Furthermore, a significant decrease in headaches, dyspnoea, dizziness and palpitations was reported (p < 0.05). There was no difference between the type of iron supplementation (intravenous versus oral) and clinical outcome data. Conclusion: Iron supplementation in iron-deficient blood donors may be an effective strategy to improve symptoms related to iron deficiency and the wellbeing of blood donors.


2010 ◽  
Vol 25 (10) ◽  
pp. 1451-1455 ◽  
Author(s):  
Vichaya Arunthari ◽  
Joseph Kaplan ◽  
Paul A. Fredrickson ◽  
Siong-Chi Lin ◽  
Pablo R. Castillo ◽  
...  

2011 ◽  
Vol 12 (3) ◽  
pp. 295-301 ◽  
Author(s):  
Colin Quinn ◽  
Mateen Uzbeck ◽  
Imran Saleem ◽  
Paul Cotter ◽  
Javed Ali ◽  
...  

1994 ◽  
Vol 23 (3) ◽  
pp. 200-203 ◽  
Author(s):  
S. T. O'KEEFFE ◽  
K. GAVIN ◽  
J. N. LAVAN

2017 ◽  
Vol 37 (04) ◽  
pp. 439-445 ◽  
Author(s):  
Barbara Felt ◽  
Tiffany Munzer

AbstractRestless legs syndrome (RLS) is a common and treatable neurologic condition in pediatric patients, with a prevalence as high as 2 to 3%. The diagnosis of RLS is made clinically based on an urge to move the legs accompanied by lower extremity discomfort that occurs during rest usually later in the day and is relieved by movement. Periodic limb movements in sleep (PLMS) can overlap with RLS, although PLMS also exists as a separate entity characterized by stereotyped movements of lower extremities in sleep. Both conditions may be highly debilitating and interfere with daily function notably in the areas of educational attainment and behavioral regulation. Iron deficiency has been implicated in the pathophysiology of both RLS and PLMS. Current evidence suggests that treatment of ferritin levels < 50 µg/L may be beneficial in improving pediatric RLS symptoms and comorbid conditions or daytime dysfunction associated with RLS. Areas for future research include (1) clarifying the ferritin or other iron status measure level which predicts iron treatment will provide symptom improvement in pediatric patients, and (2) randomized clinical trials using iron therapy to determine the degree and duration of treatment.


2018 ◽  
Vol 45 ◽  
pp. 124-131 ◽  
Author(s):  
Maria Didriksen ◽  
Richard P. Allen ◽  
Brendan J. Burchell ◽  
Lise W. Thørner ◽  
Andreas S. Rigas ◽  
...  

2016 ◽  
Vol 23 (2) ◽  
pp. 111-112 ◽  
Author(s):  
F. Crahay ◽  
D. Goossens ◽  
P. Gillet ◽  
A. Rapaille ◽  
M. Lambermont

Sign in / Sign up

Export Citation Format

Share Document